Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,933	25,006	11,703	10,129	8,835	10,576
Market Cap Growth	48.89%	113.68%	15.54%	14.65%	-16.46%	-1.18%
Enterprise Value	50,993	41,281	30,334	30,275	31,945	35,841
Last Close Price	31.36	22.04	10.44	9.12	8.01	9.65
PE Ratio	50.82	-	-	-	21.19	-
Forward PE	11.88	8.35	4.21	3.63	3.02	3.76
PS Ratio	2.13	1.51	0.74	0.68	0.56	0.64
PB Ratio	4.96	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	62.47	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	33.87	20.05	8.56	6.37	11.07	8.70
PEG Ratio	1.79	6.69	0.40	1.63	0.68	0.54
EV/Sales Ratio	3.04	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	11.10	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	14.24	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	88.22	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.61	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.49%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Invested Capital (ROIC)	8.95%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	1.97%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.60%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q